Dr. Jonathan Wang has been a Director since July 2016. Dr. Wang has over 30 years of experience in the healthcare and life sciences industries, spanning entrepreneurship, investment, research and finance. He is currently the chairman and chief executive officer of Inmagene Biopharmaceuticals (Shanghai) Co., Ltd., and was previously a partner at OrbiMed Advisors LLC.
Dr. Wang obtained his Master of Arts, Master of Philosophy, and his Ph.D. from Columbia University in the United States. He also obtained an MBA degree from Stanford University in the United States. Dr. Wang has been a member of the Biotech Advisory Panel of the Hong Kong Stock Exchange since April 2018.